A detailed history of Sterling Capital Management LLC transactions in Incyte Corp stock. As of the latest transaction made, Sterling Capital Management LLC holds 7,314 shares of INCY stock, worth $761,753. This represents 0.01% of its overall portfolio holdings.

Number of Shares
7,314
Previous 7,871 7.08%
Holding current value
$761,753
Previous $536 Million 15.72%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025

SELL
$67.27 - $86.96 $37,469 - $48,436
-557 Reduced 7.08%
7,314 $620 Million
Q2 2025

Aug 06, 2025

SELL
$55.17 - $71.22 $26,426 - $34,114
-479 Reduced 5.74%
7,871 $536 Million
Q1 2025

May 13, 2025

SELL
$60.0 - $75.26 $40,260 - $50,499
-671 Reduced 7.44%
8,350 $506 Million
Q4 2024

Feb 13, 2025

BUY
$65.08 - $83.38 $201,748 - $258,478
3,100 Added 52.36%
9,021 $623 Million
Q3 2024

Nov 12, 2024

BUY
$57.33 - $68.61 $339,450 - $406,239
5,921 New
5,921 $391 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $23.2B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Sterling Capital Management LLC Portfolio

Follow Sterling Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sterling Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sterling Capital Management LLC with notifications on news.